Cultivated Protein Turns Upstream as Costs Take Center Stage

UPSIDE Foods spins out Lucius Labs, signaling a strategic shift toward media and inputs as cultivated protein enters a more disciplined phase

30 Jan 2026

UPSIDE Foods has spun out its cell culture media operation into a separate life sciences company, marking a shift in strategy by one of the most prominent groups in cultivated meat.

The new business, Lucius Labs, will focus on developing nutrient media used to grow animal cells, a core but costly input in cell-based food production. Media has been a persistent constraint for the industry, as most formulations were designed for medical research rather than large-scale manufacturing and remain expensive to use.

By separating the unit, UPSIDE is betting that improvements in media efficiency can materially reduce production costs. Media accounts for a significant share of cultivated meat expenses, meaning incremental gains could have an outsized effect on commercial viability. Lucius Labs will draw on research previously conducted inside UPSIDE, with the aim of developing formulations tailored to food production and faster development cycles.

The move reflects a broader recalibration across alternative proteins. As investor enthusiasm for branded consumer products has eased, capital has increasingly shifted toward upstream technologies that can serve multiple customers. Lucius Labs plans to supply not only food producers but also clients in biotechnology, medical research and vaccine development, markets with different demand patterns and regulatory timelines.

Industry participants view the spinoff less as a retreat from cultivated meat than as a sign of consolidation. Technologies once treated as internal tools are emerging as standalone businesses, allowing companies to specialise and spread risk. Treating media as a standardised industrial input could make production more predictable and easier to scale.

The creation of Lucius Labs does not alter the regulatory path for cultivated meat itself. Approvals for commercial sales will continue to depend on national food regulators, and the spinoff does not signal imminent product launches.

Instead, the move underlines where competitive advantage may be shifting. As the sector matures, control over inputs such as media, rather than finished products, may play a larger role in determining cost, pace of development and eventual market access.